Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...

Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated.

That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...

Pfizer Wins Battle for Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner.

For the first time in Australia, the Italian Consulate General has partnered with Aperol, the number one cocktail in Italy, ...